EDGAR Filing Documents for 0001393905-20-000334

Form 8-K - Current report:

SEC Accession No. 0001393905-20-000334

Filing Date

2020-11-18

Accepted

2020-11-18 16:27:13

Documents

Period of Report

2020-11-12

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	rtsl_8k.htm	8-K	86107
2	FIRST AMENDMENT TO ASSET PURCHASE AND SALES AGREEMENT DATED NOVEMBER 16, 2020	rtsl_ex22.htm	EX-2.2	75274
3	CERTIFICATE OF DESIGNATION FILED WITH THE SECRETARY OF STATE OF NEVADA ON NOVEMB	rtsl_ex31.htm	EX-3.1	105923
4	EMPLOYMENT AGREEMENT ENTERED INTO BETWEEN RAPID THERAPEUTIC SCIENCE LABORATORIES	rtsl_ex101.htm	EX-10.1	99557
5	EMPLOYMENT AGREEMENT ENTERED INTO BETWEEN RAPID THERAPEUTIC SCIENCE LABORATORIES	rtsl_ex102.htm	EX-10.2	101767
6	ASSIGNMENT OF INTELLECTUAL PROPERTY AGREEMENT DATED NOVEMBER 16, 2020	rtsl_ex103.htm	EX-10.3	37677
7	TRADING AGREEMENT DATED NOVEMBER 16, 2020, BETWEEN FRANK GILL AND RAPID THERAPEU	rtsl_ex104.htm	EX-10.4	39159
8	TRADING AGREEMENT DATED NOVEMBER 16, 2020, BETWEEN FRANK GILL, RYAN JOHNSON AND	rtsl_ex105.htm	EX-10.5	35424
9		rtslimg1.jpg	GRAPHIC	152383
	Complete submission text file	0001393905-20-000334.txt		792671

Mailing Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240

Business Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240 214-236-1363

Rapid Therapeutic Science Laboratories, Inc. (Filer) CIK: 0001575659 (see all company filings)